-
1
-
-
71749091235
-
Prediction of adjuvant chemotherapy benefit in endocrine responsive, early breast cancer using multigene assays
-
Albain KS, Paik S, van't Veer L. Prediction of adjuvant chemotherapy benefit in endocrine responsive, early breast cancer using multigene assays. Breast 2009;18(suppl 3):S141-S145.
-
(2009)
Breast
, vol.18
, Issue.SUPPL. 3
-
-
Albain, K.S.1
Paik, S.2
Van'T, V.L.3
-
2
-
-
60849097255
-
Gene-expression signatures in breast cancer
-
Sotiriou C, Pusztai L. Gene-expression signatures in breast cancer. N Engl J Med 2009;360: 790-800.
-
(2009)
N Engl J Med
, vol.360
, pp. 790-800
-
-
Sotiriou, C.1
Pusztai, L.2
-
3
-
-
82355164800
-
The effect of Oncotype DX recurrence score on treatment recommendations for patients with estrogen receptor- positive early stage breast cancer and correlation with estimation of recurrence risk by breast cancer specialists
-
Joh JE, Esposito NN, Kiluk JV et al. The effect of Oncotype DX recurrence score on treatment recommendations for patients with estrogen receptor- positive early stage breast cancer and correlation with estimation of recurrence risk by breast cancer specialists. The Oncologist 2011;16: 1520-1526.
-
(2011)
The Oncologist
, vol.16
, pp. 1520-1526
-
-
Joh, J.E.1
Esposito, N.N.2
Kiluk, J.V.3
-
4
-
-
82355164826
-
Impact of multigene assays in early stage breast cancer
-
Lo SS, Albain KS. Impact of multigene assays in early stage breast cancer. The Oncologist 2011;16: 1482-1483.
-
(2011)
The Oncologist
, vol.16
, pp. 1482-1483
-
-
Lo, S.S.1
Albain, K.S.2
-
5
-
-
73249140371
-
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with nodepositive, oestrogen-receptor-positive breast cancer on chemotherapy: A retrospective analysis of a randomised trial
-
Albain KS, Barlow WE, Shak S et al. Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with nodepositive, oestrogen-receptor-positive breast cancer on chemotherapy: A retrospective analysis of a randomised trial. Lancet Oncol 2010;11:55-65.
-
(2010)
Lancet Oncol
, vol.11
, pp. 55-65
-
-
Albain, K.S.1
Barlow, W.E.2
Shak, S.3
-
6
-
-
78049453780
-
A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancer
-
Nielsen TO, Parker JS, Leung S et al. A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancer. Clin Cancer Res 2010;16:5222-5232.
-
(2010)
Clin Cancer Res
, vol.16
, pp. 5222-5232
-
-
Nielsen, T.O.1
Parker, J.S.2
Leung, S.3
-
7
-
-
84866544308
-
Molecular tumor characteristics influence adjuvant endocrine treatment outcome
-
Bianchini G, Pusztai L, Iwarnoto T et al. Molecular tumor characteristics influence adjuvant endocrine treatment outcome. Cancer Research 2011; 71(suppl 3):S1-S7.
-
(2011)
Cancer Research
, vol.71
, Issue.SUPPL. 3
-
-
Bianchini, G.1
Pusztai, L.2
Iwarnoto, T.3
-
8
-
-
77957935139
-
Genomic index of sensitivity to endocrine therapy for breast cancer
-
Symmans WF, Hatzis C, Sotiriou C et al. Genomic index of sensitivity to endocrine therapy for breast cancer. J Clin Oncol 2010;28:4111-4119.
-
(2010)
J Clin Oncol
, vol.28
, pp. 4111-4119
-
-
Symmans, W.F.1
Hatzis, C.2
Sotiriou, C.3
-
9
-
-
77951637777
-
Prediction of risk of distant recurrence using the 21-gene recurrence score in node-negative and node-positive postmenopausal patients with breast cancer treated with anastrozole or tamoxifen: A TransATAC study
-
Dowsett M, Cuzick J, Wale C et al. Prediction of risk of distant recurrence using the 21-gene recurrence score in node-negative and node-positive postmenopausal patients with breast cancer treated with anastrozole or tamoxifen: a TransATAC study. J Clin Oncol 2010;28:1829-1834.
-
(2010)
J Clin Oncol
, vol.28
, pp. 1829-1834
-
-
Dowsett, M.1
Cuzick, J.2
Wale, C.3
|